Mechanism of intragastric nicotine protection against ethanol-induced gastric injury
- 1 January 1991
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 36 (1) , 39-46
- https://doi.org/10.1007/bf01300085
Abstract
To elucidate the mechanism of intragastric nicotine protection against ethanol-induced gastric mucosal injury seen in a previous report and in our preliminary study, the following studies were performed. Rats were pretreated with naloxone (8 mg/kg intraperitoneal, 0.5 hr prior to study) to block opiate receptors; or capsaicin (125 mg/kg subcutaneous 10 days prior to study) to denervate the afferent sensory fibers; or indomethacin (2.5 mg/kg intragastric or 5 mg/kg subcutaneous, 1 hr prior to study) to inhibit endogenous prostaglandin synthesis. At 1-hr intervals, nicotine (4 mg/kg) or vehicle and 40% ethanol were then given intragastrically. Total gastric corpus mucosal lesion length was measured unbiasedly. In separate studies, gastric mucosal blood flow (GMBF) was assessed by hydrogen gas clearance before and after intragastric nicotine or vehicle; luminal mucus volume, gastric juice volume, and acid output were measured 1 hr after either intragastric nicotine or vehicle administration. The results showed that the acute protective effect of intragastric nicotine was associated with a significantly larger luminal mucus volume. It was not blocked by naloxone, capsaicin, or indomethacin. There was no increase in GMBF. The larger gastric residual volume did not account for the protection. We conclude that the mechanism mediating nicotine protection is unique and is independent of opiate receptors, capsaicin-sensitife afferent sensory nerve fibers, endogenous prostaglandin generation, or dilution of the injurious agent. The increase in luminal gastric mucus volume may contribute to the protective effect of intragastric nicotine against gastric mucosal injury produced by 40% ethanol.Keywords
This publication has 40 references indexed in Scilit:
- Effect of [D-Met2,Pro5]enkephalinamide on gastric ulceration and transmucosal potential differenceEuropean Journal of Pharmacology, 1988
- Effects of morphine and naloxone on stress ulcer formation and gastric acid secretionEuropean Journal of Pharmacology, 1986
- Adherent and soluble mucus in the stomach and duodenumDigestive Diseases and Sciences, 1985
- Morphine Potentiates the Gastroulcerogenic Effect of Indometacin in RatsPharmacology, 1985
- Decreased acid secretion and gastric lesion production by morphine in ratsEuropean Journal of Pharmacology, 1984
- Met- and leu-enkephalin immuno- and bio-reactivity in human stomach and pancreasLife Sciences, 1982
- Evidence of an involvement of the opioid deptidergic system in the reaction to stressful conditionsEuropean Journal of Pharmacology, 1980
- Absorption of nicotine by the human stomach and its effect on gastric ion fluxes and potential differenceDigestive Diseases and Sciences, 1978
- ENKEPHALIN-LIKE IMMUNOREACTIVITY IN THE HUMAN GASTROINTESTINAL TRACTThe Lancet, 1977
- The Croonian Lecture: Mucin and the protection of the bodyProceedings of the Royal Society of London. B. Biological Sciences, 1955